Aura Biosciences (AURA) Change in Account Payables (2020 - 2026)
Aura Biosciences (AURA) posted Change in Account Payables of $1.0 million for Q1 2026, up 338.14% on a QoQ basis from -$430000.0 in Q4 2025, and up 443.62% year-over-year from $188365.4 in Q1 2025.
Aura Biosciences (AURA) Change in Account Payables (2020 - 2026) Analysis & Trends
Aura Biosciences' Change in Account Payables history runs 7 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Change in Account Payables rose 443.62% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $476000.0 (up 195.65% YoY) and the FY2025 annual result came in at -$846000.0, down 275.52% from the prior year.
- Change in Account Payables was $1.0 million for Q1 2026 at Aura Biosciences, up from -$430000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.0 million in Q1 2026 and bottomed at -$1.9 million in Q1 2023.
- A 5-year average of -$2352.9 and a median of $23000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 524.54% — and 2025, when it tumbled 1395.65%.
- Aura Biosciences' Change in Account Payables stood at $1.0 million in 2022, then plunged by 55.11% to $457000.0 in 2023, then tumbled by 32.17% to $310000.0 in 2024, then sank by 238.71% to -$430000.0 in 2025, then surged by 338.14% to $1.0 million in 2026.
- Business Quant data shows AURA's Change in Account Payables at $1.0 million in Q1 2026, -$430000.0 in Q4 2025, and $602000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | -430,000.00 |
| Dec 31, 2025 | -430,000.00 |
| Sep 30, 2025 | 602,000.00 |
| Sep 30, 2025 | 602,000.00 |
| Jun 30, 2025 | -720,000.00 |
| Jun 30, 2025 | -720,000.00 |
| Mar 31, 2025 | -298,000.00 |
| Mar 31, 2025 | -298,000.00 |
| Dec 31, 2024 | 310,000.00 |
| Dec 31, 2024 | 310,000.00 |
| Sep 30, 2024 | 689,000.00 |
| Sep 30, 2024 | 689,000.00 |
| Jun 30, 2024 | -540,000.00 |
| Jun 30, 2024 | -540,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | 457,000.00 |
| Dec 31, 2023 | 457,000.00 |